These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6364091)

  • 21. Affinities of beta-lactams for penicillin binding proteins of Chlamydia trachomatis and their antichlamydial activities.
    Storey C; Chopra I
    Antimicrob Agents Chemother; 2001 Jan; 45(1):303-5. PubMed ID: 11120983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of beta-lactamase on minimum inhibitory concentrations of methicillin in methicillin-resistant Staphylococcus aureus.
    Sasatsu M; Miyazawa K; Noguchi N; Kono M
    Microbios; 1994; 78(316):145-53. PubMed ID: 8041291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The antimicrobial activity of cefpirome, a new cephalosporin.
    Wise R; Andrews JM; Cross C; Piddock LJ
    J Antimicrob Chemother; 1985 Apr; 15(4):449-56. PubMed ID: 3874198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Penicillin-binding proteins involved in high-level piperacillin resistance in Veillonella spp.
    Theron MM; van Rensburg MN; Chalkley LJ
    J Antimicrob Chemother; 2003 Jul; 52(1):120-2. PubMed ID: 12805259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro investigation of BK-218, a new oral and parenteral cephalosporin.
    Szabó I; Barabás J; Tar A; Kiss L; Filep M; Schmidt T; Marossy K; Tóth-Martinez B; Barabás G; Hernádi F
    Antimicrob Agents Chemother; 1990 Feb; 34(2):349-54. PubMed ID: 2109582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity of CGP 31523A, a broad-spectrum cephalosporin, in comparison with those of other agents.
    Wise R; Cross C; Andrews JM
    Antimicrob Agents Chemother; 1984 Dec; 26(6):876-80. PubMed ID: 6524904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Penicillin-binding protein sensitive to cephalexin in sporulation of Bacillus cereus.
    Miyamoto T; Yamaguchi K; Abu Sayed M; Sasahara R; Honjoh K; Hatano S
    Microbiol Res; 1997 Sep; 152(3):227-32. PubMed ID: 9352657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiological aspects of antibiotic resistance in respiratory pathogens.
    Mlynarczyk G; Mlynarczyk A; Jeljaszewicz J
    Int J Antimicrob Agents; 2001 Dec; 18(6):497-502. PubMed ID: 11738335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activities and targets of three cephem antibiotics against Haemophilus influenzae.
    Mendelman PM; Henritzy LL; Chaffin DO; Lent K; Smith AL; Stull TL; Wiley EA
    Antimicrob Agents Chemother; 1989 Nov; 33(11):1878-82. PubMed ID: 2610499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Virulence of non-beta-lactamase-mediated ampicillin-resistant Haemophilus influenzae.
    Rubin LG; Mendelman PM; Rakita RM; Rosen H
    FEMS Microbiol Lett; 1991 Nov; 68(1):27-31. PubMed ID: 1769551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BMY 28100, a new oral cephalosporin.
    Leitner F; Pursiano TA; Buck RE; Tsai YH; Chisholm DR; Misiek M; Desiderio JV; Kessler RE
    Antimicrob Agents Chemother; 1987 Feb; 31(2):238-43. PubMed ID: 3105449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Summary of laboratory studies on the antibacterial activity of cefaclor.
    Preston DA
    Infection; 1979; 7 Suppl 6():557-61. PubMed ID: 45088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro comparison of cefazolin with other cephalosporins.
    Yeivin R; Meshulam M; Sacks T
    Isr J Med Sci; 1974 Sep; 10(9):1092-5. PubMed ID: 4436031
    [No Abstract]   [Full Text] [Related]  

  • 34. Antimicrobial activity of LY163892, an orally administered 1-carbacephem.
    Jones RN; Barry AL
    J Antimicrob Chemother; 1988 Sep; 22(3):315-20. PubMed ID: 3182429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of cephalothin and cephalexin on various bacterial species isolated from biological material in the Regional Hygienic Station Bratislava].
    Simkovicová M; Hausmannová Z; Sobotová Z
    Cas Lek Cesk; 1976 May; 115(20-21):612-6. PubMed ID: 776399
    [No Abstract]   [Full Text] [Related]  

  • 36. Cephalexin: microbiological effects and pharmacologic parameters in man.
    Meyers BR; Kaplan K; Weinstein L
    Clin Pharmacol Ther; 1969; 10(6):810-6. PubMed ID: 4900202
    [No Abstract]   [Full Text] [Related]  

  • 37. Rifampicin: a new rifamycin. I. Bacteriological studies.
    Arioli V; Pallanza R; Furesz S; Carniti G
    Arzneimittelforschung; 1967 May; 17(5):523-9. PubMed ID: 4385644
    [No Abstract]   [Full Text] [Related]  

  • 38. Cephalexin, a new orally absorbed cephalosporin antibiotic.
    Wick WE
    Appl Microbiol; 1967 Jul; 15(4):765-9. PubMed ID: 4383049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Some bacterial species isolated in medical institutions of Bratislava. A survey of their sensitivities to cephalexin and cephalotin (author's transl)].
    Sónak R; Antolová T; Breierová A; Dunová A; Jakubovská M; Pavlinská M; Poór J
    Cas Lek Cesk; 1976 May; 115(20-21):617-9. PubMed ID: 1277246
    [No Abstract]   [Full Text] [Related]  

  • 40. Mechanism and implication of cephalosporin penetration into oropharyngeal mucosa.
    Najjar TA; Alkharfy KM; Saad SY
    J Infect Chemother; 2009 Apr; 15(2):70-4. PubMed ID: 19396515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.